LAM Therapeutics Scores $58 Million and a New Clinical Program in Cancer Post author:Sam Post published:March 29, 2017 Post category:BioPharma Life Sciences Jobs … Source: BioSpace You Might Also Like Aeglea BioTherapeutics Updates Phase I/II Trial Data March 12, 2018 Egalet Reports First Quarter 2017 Financial Results May 9, 2017 Becton, Dickinson and Company Prices Offerings Of $2.25 Billion Of Common Stock And $2.25 Billion Of Depositary Shares Representing Interests In Mandatory Convertible Preferred Stock May 10, 2017
Becton, Dickinson and Company Prices Offerings Of $2.25 Billion Of Common Stock And $2.25 Billion Of Depositary Shares Representing Interests In Mandatory Convertible Preferred Stock May 10, 2017